MedPath

Meloxicam

Generic Name
Meloxicam
Brand Names
Anjeso, Mobic, Qmiiz, Vivlodex
Drug Type
Small Molecule
Chemical Formula
C14H13N3O4S2
CAS Number
71125-38-7
Unique Ingredient Identifier
VG2QF83CGL

Overview

Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) used to relieve various types of pain, including pain caused by musculoskeletal conditions, osteoarthritis, and rheumatoid arthritis. With a longer half-life than most other NSAIDS, it is a favorable option for those who require once-daily dosing. Meloxicam is available in oral, transdermal, and intravenous formulations. It is a preferential COX-2 inhibitor, purportedly reducing the risk of adverse gastrointestinal tract effects, however, this is a topic of controversy.

Background

Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) used to relieve various types of pain, including pain caused by musculoskeletal conditions, osteoarthritis, and rheumatoid arthritis. With a longer half-life than most other NSAIDS, it is a favorable option for those who require once-daily dosing. Meloxicam is available in oral, transdermal, and intravenous formulations. It is a preferential COX-2 inhibitor, purportedly reducing the risk of adverse gastrointestinal tract effects, however, this is a topic of controversy.

Indication

Meloxicam is indicated for the symptomatic treatment of arthritis and osteoarthritis. In addition, it is indicated for the pauciarticular and polyarticular course of Juvenile Rheumatoid Arthritis (JRA) in patients aged 2 years old or above. Off-label uses include the treatment of dental or post-surgical pain. In addition to the above, meloxicam has also been studied in the treatment of neuropathic pain. Meloxicam, in combination with bupivacaine, is indicated for postsurgical analgesia in adult patients for up to 72 hours following foot and ankle, small-to-medium open abdominal, and lower extremity total joint arthroplasty surgical procedures.

Associated Conditions

  • Dental Pain
  • Neuropathic Pain
  • Osteoarthritis (OA)
  • Pain, Inflammatory
  • Pauciarticular juvenile rheumatoid arthritis
  • Polyarticular juvenile rheumatoid arthritis, chronic or unspecified
  • Postoperative pain
  • Rheumatoid Arthritis

FDA Approved Products

Meloxicam
Manufacturer:Blenheim Pharmacal, Inc.
Route:ORAL
Strength:15 mg in 1 1
Approved: 2011/06/08
NDC:10544-251
Meloxicam
Manufacturer:Aurobindo Pharma Limited
Route:ORAL
Strength:7.5 mg in 1 1
Approved: 2021/05/07
NDC:65862-097
Meloxicam
Manufacturer:Aurobindo Pharma Limited
Route:ORAL
Strength:15 mg in 1 1
Approved: 2021/05/07
NDC:65862-098
Meloxicam
Manufacturer:Aphena Pharma Solutions - Tennessee, LLC
Route:ORAL
Strength:7.5 mg in 1 1
Approved: 2020/01/20
NDC:71610-380
Meloxicam
Manufacturer:Rising Pharma Holdings, Inc.
Route:ORAL
Strength:15 mg in 1 1
Approved: 2021/06/04
NDC:16571-777

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath